UCB (UCBJY) News Today $100.91 +1.46 (+1.47%) As of 03:50 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartDividendHeadlinesSEC FilingsShort InterestBuy This Stock UCBJY Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period UCB (UCBJY) Upgraded to Strong Buy: What Does It Mean for the Stock?July 16 at 6:22 AM | msn.comUCB SA’s Growth Potential: Buy Rating on Bimzelx’s Transformative ImpactJuly 16 at 2:48 AM | tipranks.comHere's What Could Help UCB (UCBJY) Maintain Its Recent Price ... - NasdaqJuly 11, 2025 | nasdaq.comHere's What Could Help UCB (UCBJY) Maintain Its Recent Price StrengthJuly 9, 2025 | msn.comShort Interest in UCB SA (OTCMKTS:UCBJY) Rises By 165.6%June 13, 2025 | marketbeat.comShort Interest in UCB SA (OTCMKTS:UCBJY) Rises By 166.7%May 31, 2025 | marketbeat.comUCB (OTCMKTS:UCBJY) Shares Cross Above 50-Day Moving Average - Here's WhyMay 26, 2025 | marketbeat.comUCB (OTCMKTS:UCBJY) Shares Pass Below 50-Day Moving Average - Here's What HappenedApril 30, 2025 | marketbeat.comUCB SA (OTCMKTS:UCBJY) Short Interest UpdateApril 28, 2025 | marketbeat.comUCB SA (OTCMKTS:UCBJY) Increases Dividend to $0.48 Per ShareApril 23, 2025 | marketbeat.comUCB (OTCMKTS:UCBJY) Stock Crosses Below Fifty Day Moving Average - Here's WhyApril 17, 2025 | marketbeat.comUCB SA (OTCMKTS:UCBJY) Short Interest Down 76.3% in MarchApril 17, 2025 | marketbeat.comUCB (OTCMKTS:UCBJY) Stock Price Crosses Below 200 Day Moving Average - Should You Sell?April 6, 2025 | marketbeat.comTD Cowen maintains UCB stock Buy rating, EUR250 targetMarch 27, 2025 | uk.investing.comUCB (OTCMKTS:UCBJY) Shares Pass Above 50-Day Moving Average - Time to Sell?March 20, 2025 | marketbeat.comUCB SA (OTCMKTS:UCBJY) Sees Significant Increase in Short InterestMarch 13, 2025 | marketbeat.comUCB (OTCMKTS:UCBJY) Shares Cross Below 50-Day Moving Average - Time to Sell?March 11, 2025 | marketbeat.comUCB (OTCMKTS:UCBJY) Hits New 12-Month High - What's Next?March 4, 2025 | marketbeat.comUCB (OTCMKTS:UCBJY) Stock Crosses Above 200 Day Moving Average - Should You Sell?February 15, 2025 | marketbeat.comUCB SA (UCBJY)February 2, 2025 | finance.yahoo.comUCB (OTCMKTS:UCBJY) Share Price Crosses Below Fifty Day Moving Average - Time to Sell?January 21, 2025 | marketbeat.comUCB Announces U.S. Availability of 320 mg/2 mL Single-Injection Administration Option for BIMZELX® (bimekizumab-bkzx)January 17, 2025 | finance.yahoo.comUCB (OTC:UCBJY) Stock Quotes, Forecast and News SummaryNovember 22, 2024 | benzinga.comFDA Approves UCB's Psoriasis Drug For Expanded Use In Painful Inflammatory Skin DiseaseNovember 20, 2024 | benzinga.comBiogen, UCB release phase 3 data on lupus candidate dapirolizumabNovember 19, 2024 | msn.comUCB (OTCMKTS:UCBJY) Sets New 12-Month High - What's Next?November 5, 2024 | marketbeat.comOruka draws buy at Stifel on potential against psoriasisOctober 11, 2024 | msn.comUCB Presents New 4-year Data for BIMZELX® (bimekizumab-bkzx) in Moderate-to-Severe Plaque Psoriasis at EADV 2024September 26, 2024 | finance.yahoo.comBiogen/UCB Partnered Autoimmune Disease Candidate Hits Primary Goal In Late-Stage Study, Sets Stage Another Pivotal TrialSeptember 24, 2024 | finance.yahoo.comUCB gets expanded FDA approval for psoriasis drug BimzelxSeptember 23, 2024 | seekingalpha.comUCB United Community Banks, Inc.August 29, 2024 | seekingalpha.comBarclays Sticks to Its Buy Rating for UCB SA (0NZT)August 27, 2024 | markets.businessinsider.comBelgium-Based Pharma Firm UCB To Offload China Neurology, Allergy Business For $680M To Asset Management CompaniesAugust 26, 2024 | msn.comDAY BY DAY Upgrades UCB SA - Depositary Receipt () (UCBJY)August 12, 2024 | msn.comBarclays Remains a Buy on UCB SA (0NZT)July 29, 2024 | markets.businessinsider.comUBS Keeps Their Buy Rating on UCB SA (0NZT)July 26, 2024 | markets.businessinsider.comUCB SA's Dividend AnalysisApril 25, 2024 | finance.yahoo.comDrugmakers reportedly planning to raise prices on 500+ drugs in January (update)December 29, 2023 | seekingalpha.comDrugmakers reportedly planning to raise prices on 500+ drugs in JanuaryDecember 29, 2023 | msn.comFDA’s new drug approvals for 2023 rise 51% from last yearDecember 28, 2023 | msn.comUCB presents new data advancing patient-focused scientific leadership at American Epilepsy Society Annual MeetingDecember 1, 2023 | finance.yahoo.comUCB Announces U.S. Availability of BIMZELX® for the Treatment of Adults with Moderate-to-Severe Plaque PsoriasisNovember 14, 2023 | finance.yahoo.comFDA approves UCB's Bimzelx for plaque psoriasisOctober 18, 2023 | msn.comUCB presents late-breaking posters at Child Neurology Society MeetingOctober 4, 2023 | benzinga.comEMA advisors recommend many new meds at latest meetingSeptember 15, 2023 | msn.comSkin Disease Focused MoonLake Immunotherapeutics Poised To Outshine Rivals, Analyst AssertsAugust 31, 2023 | markets.businessinsider.comCrohn's disease drugmakers set to benefit from expected rise in casesAugust 26, 2023 | msn.comUCB (UCBJY) Declares $0.73 DividendApril 13, 2023 | msn.comUnited Commercial Bank Ltd.April 6, 2023 | wsj.comBimekizumab Phase 3 Data in Hidradenitis Suppurativa Show Clinically Meaningful, Deep and Maintained Response over 48 WeeksMarch 20, 2023 | benzinga.com Get UCB News Delivered to You Automatically Sign up to receive the latest news and ratings for UCBJY and its competitors with MarketBeat's FREE daily newsletter. Email Address UCBJY Media Mentions By Week UCBJY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. UCBJY News Sentiment▼1.050.96▲Average Medical News Sentiment UCBJY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. UCBJY Articles This Week▼40▲UCBJY Articles Average Week Get UCB News Delivered to You Automatically Sign up to receive the latest news and ratings for UCBJY and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CHGCY News Today ZTS News Today TAK News Today DSNKY News Today ONC News Today SDZNY News Today SMMT News Today ALPMY News Today MKKGY News Today SGIOY News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:UCBJY) was last updated on 7/17/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBanks aren’t ready for this altcoin—are you?The Secret Crypto That Billionaires Are Hoarding When these hit, the current price will look like pocket ch...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UCB SA Please log in to your account or sign up in order to add this asset to your watchlist. Share UCB With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
